Clinical Trial

Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined With Chemotherapy and Concurrent Low-Dose Radiotherapy (LDRT) for the Treatment of Extensive-Stage Small Cell Lung Cancer (SCLC)

Study acronym: SKY
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined with Chemotherapy and Concurrent Low-Dose Radiotherapy (LDRT) for the Treatment of Extensive-Stage Small Cell Lung Cancer (SCLC)
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-09-23.
Status change: Not Yet Recruiting → Recruiting 2026-02-04
Trial Details
NCT Number NCT06610734
Lead Sponsor Sichuan University
Collaborators: Shanghai Shengdi Pharmaceutical Co., Ltd
Conditions Small Cell Lung Cancer Extensive Stage
Enrollment 202 participants
Start Date 2024-12-23
Primary Completion 2026-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-02-09